Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Humanigen, Inc. (HGEN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.4000+0.0200 (+5.26%)
At close: 04:00PM EDT
0.4085 +0.01 (+2.12%)
After hours: 07:59PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
MACD

MACD

Previous Close0.3800
Open0.3702
Bid0.4000 x 900
Ask0.4090 x 1000
Day's Range0.3702 - 0.4115
52 Week Range0.3600 - 18.6500
Volume13,912,184
Avg. Volume7,296,211
Market Cap28.253M
Beta (5Y Monthly)-1.22
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for HGEN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Humanigen, Inc.
    Analyst Report: AbbVie Inc.AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
    Rating
    Fair Value
    Economic Moat
    3 days agoMorningstar
View more
Advertisement
Advertisement